Extract
Pulmonary function tests (PFTs) remain of foremost relevance to the management of patients with respiratory diseases. The recently published European Respiratory Society (ERS)/American Thoracic Society (ATS) document on testing interpretation is therefore poised to influence the way pulmonologists teach, describe and quantify respiratory physiological impairment [1]. A careful appraisal of its main recommendations is key to avoiding undesirable clinical consequences of any potential shortcomings.
Abstract
Despite some advances, the new @EuroRespSoc/@ATScommunity guidelines on pulmonary function tests interpretation still present with relevant limitations that may have negative clinical implications for individual subjectshttps://bit.ly/36rKyIQ
Footnotes
利益冲突:J.A。内德没有什么可披露的。
- ReceivedFebruary 4, 2022.
- AcceptedFebruary 17, 2022.
- 复制right ©The authors 2022. For reproduction rights and permissions contactpermissions{at}ersnet.org